Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-19-014345
Filing Date
2019-10-07
Accepted
2019-10-07 11:58:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27455
2 filename2.txt TEXT-EXTRACT 992
  Complete submission text file 0000000000-19-014345.txt   39480
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filed for) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)